MAPRx strongly supports CMS’ proposal to permit coverage of anti-obesity medications to treat obesity for appropriate indications. AOMs are a critical component of the continuum of obesity care. Read our Comment Letter
...MAPRx in Action
2026 Part D Proposed Rule Comments
MAPx appreciates the opportunity to comment on specific provisions in the CY 2026 policy and technical changes to MA and Part D. Read the Comment Letter
...2025 Medicare Part D Open Enrollment
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2024 – December 7, 2024 for coverage beginning January 1, 2025. Plans make changes to benefits and costs, and there are also many new changes for the 2025 plan year.
MAPRx encourages both new and existing...
IRA Patient Guide
New this year: Medicare Part D prescription drug plans will have an out-of-pocket maximum of $2,000 and beneficiaries can also opt in to the Medicare Prescription Payment Plan (MPPP)—a new program that lets you pay for prescriptions in monthly installments. The MAPRx Coalition has created this new patient guide with more information.
The Inflation Reduction Act’s Unintended
Consequences for Medicare Part D in 2025 and 2026
The IRA enacted the most significant changes to Part D since its inception, and these reforms have major implications for Medicare beneficiaries. In this new paper, the MAPRx Coalition examines the potential impact of three of IRA's major Part D provisions.
RE: Medicare Prescription Payment Plan Model Documents
The MAPRx Coalition (MAPRx) appreciates the opportunity to provide the Centers for Medicare & Medicaid Services (CMS) with comments regarding the new model documents for the implementation of the Medicare Prescription Payment Plan (MPPP) program set to take effect for Contract Year (CY) 2025.
The MAPRx Coalition is pleased that CMS has made several important changes to the Part D Reporting Requirements, many of which the Coalition advocated for in our April 2 comments.
...Medicare Part D Reporting Requirements (CMS-10185)
The MAPRx Coalition appreciates the opportunity to provide the Centers for Medicare & Medicaid Services (CMS) with comments regarding Medicare Part D plan sponsor data reporting requirements, as requested in the notice published in the Federal Register on February 2, 2024.
Highlights include:
• Part D plan...
Comprehensive Obesity Coverage in Medicare Part D
MAPRx urges Congress and CMS to establish comprehensive obesity coverage in Medicare Part D through a one pager.
Highlights include:
• Treat and Reduce Obesity Act: Bipartisan, bicameral legislation to establish anti-obesity medication coverage through Medicare Part D
• CMS Guidance: to establish AOM coverage thorough revised Part...